Viceroy

@viceroyresearch

A group of individuals that see the world differently.

Vrijeme pridruživanja: prosinac 2016.

Tweetovi

Blokirali ste korisnika/cu @viceroyresearch

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @viceroyresearch

  1. Prikvačeni tweet
    22. lis 2019.

    After consultation with industry specialists and oncologists, Viceroy believes Athenex’s flagship drug, Oraxol, cannot compete with the current standard of care available in the USA. 1/2

    Prikaži ovu nit
    Poništi
  2. 6. pro 2019.

    Catch Viceroy's chatting with on Athenex and a bunch of stuff we've done in the past.

    Poništi
  3. 5. pro 2019.

    Looks like used the playbook & are taking no chances with their 'results.' Tapping investors for $60mm. Confidence levels in the results must be low to 'need' cash now. The presentation just got diluted.

    Poništi
  4. proslijedio/la je Tweet
    26. stu 2019.

    MiMedx was meant to be Parker Petit's last act -- the final chapter of a decades-long business career. On Tuesday, he was indicted for accounting fraud, following a long battle with , and . Story on

    Prikaži ovu nit
    Poništi
  5. proslijedio/la je Tweet
    26. stu 2019.

    Its important to note the energy and work put into .. Everyone had a different angle and if not for speaking iut and exposing a Criminal Enterprise Parker and his thugs would still be at it

    Poništi
  6. 26. stu 2019.

    SEC vs. MiMedx - Complaint live thanks to Viceroy is also suing MiMedx.

    Poništi
  7. 26. stu 2019.

    MiMedx hires government investigation specialist on the same day the former CEO and COO are both indicted. If you'd like our summary of over 20 reports we have written on , please follow the below link:

    Poništi
  8. 25. stu 2019.

    Crickets from as we move into another week of trading without a completed facility.

    Poništi
  9. 20. stu 2019.

    A summary of our reporting to Athenex to date:

    Poništi
  10. 20. stu 2019.

    Here's some more sample photos of the "completed" facility in Chongqing. You can find more in our report:

    Poništi
  11. 20. stu 2019.

    Last week, Viceroy released its anonymized copy of a comissioned independent report on the veracity of Oraxol. You can find this report here:

    Poništi
  12. 20. stu 2019.

    Athenex’s SABCS presentation is the same as the one announced on September 23. RBC reiteration of an outperform on a “SABCS win” sounds ridiculous considering it is the same data that prompted an unremarkable title 2 months earlier, & crashed the stock when it was released.

    Poništi
  13. 20. stu 2019.

    On November 19, 2019 Athenex announced the title of their presentation at the San Antonio Breast Cancer Symposium. This is a blatant strategy to pump the price of by changing the title of the presentation which has had no change in content since its submission in June 2019

    Poništi
  14. 20. stu 2019.

    Promotional press releases in China appear to include stock images of laboratories and images of a completed Athenex lobby to paint a pretty picture of the progress. Management back to their old ways of swindling investors. 3/3

    Prikaži ovu nit
    Poništi
  15. 20. stu 2019.

    The site is unoccupied save for construction workers. Everyone is wearing a hard-hat. There are no sealed roads. There is no ramp into the elevated entry. have portrayed this building as their new site. Our on-the-ground investigators confirm this is false. 2/3

    Prikaži ovu nit
    Poništi
  16. 20. stu 2019.

    Here is new API plant, referenced against their promo pics we found on state sponsored Chinese press. Hilariously, Athenex still held their completion ceremony at this park on 19 Sep, despite the entire building being covered with scaffolding. 1/3

    Prikaži ovu nit
    Poništi
  17. 20. stu 2019.

    Investigators visited Chongqing International Bio-City, cited as the new Chinese home for , only to be advised that the company is not located within the business park. The actual facility is some 25 miles away, heavily under construction, and unoccupied.

    Poništi
  18. 20. stu 2019.

    Viceroy's on-the ground investigation of Athenex’s Chongqing factory show the new API plant is still heavily under construction, ~40km away from cited location. Claims of completed validation for commercialization in H1 2020 are false.

    Poništi
  19. 19. stu 2019.

    We remain short Athenex - absurd that bouncing on presentation of results in 2 weeks, that have been available for months to management.

    Poništi
  20. proslijedio/la je Tweet
    19. stu 2019.

    SHORT ... up on being selected to present at the SABCS? ... guess ... It's giving me another opp to short the spike!

    Poništi
  21. 13. stu 2019.

    We elected to file our findings with the SEC, FDA & New York Governor. Management have failed to address/refute a single issue we have raised, despite claiming innacuracies in our data. 8/8

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·